In this report, we show that human NOP14, a 40S ribosome biogenesis factor whose expression is upregulated in cancer cells, plays a pivotal role in mTORC2-Akt signaling by creating ribosome-coated ER as a platform for mTORC2 activation. The gene discussed is NOP14; the disease is cancer.